Form 4 for VNDA Vanda Pharmaceuticals Inc.
Accepted 2023-08-23 00:00:00 ET · period of report 2023-08-21 · accession 0001209191-23-047056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-23 | 2023-08-21 | VNDA | Wijkstrom Joakim | SVP, CMO | S - Sale | $5.84 | -3,724 | 113.8K | -3% | -$21.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-21 | S | D | 3,724 | $5.84 | 113,816 | D | — | — |